NCT06596473 2026-03-05A Study of BG-C477 in Participants With Advanced Solid TumorsBeOne MedicinesPhase 1 Recruiting310 enrolled
NCT04716634 2025-03-25Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid TumorsBeiGenePhase 2 Completed84 enrolled 17 charts